{"transactions":[{"id":4637369,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":21219,"kind":"person","name":"HERSHBERG ROBERT","position":1,"cik":"0001274139","reported_name":"HERSHBERG ROBERT","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-10-07T22:08:23.000Z","date":"2026-10-06","kind":"exercise","planned":true,"acquired":false,"shares":25000,"price":2.22,"value":55500.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"One forty-eighth (1/48th) of the shares subject to the award shall vest one month after March 16, 2020, or the Vesting Commencement Date, and one forty-eighth (1/48th) of the shares subject to the award shall vest each month thereafter on the same day of the month as the Vesting Commencement Date. Date exercisable varies by tranche."}],"balance_after":500000,"derivative":{"exercise_price":2.22,"expiration_date":"2030-03-19","underlying":"Class A Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001601830-26-000119","document":"wk-form4_1791410900.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1601830/000160183026000119/wk-form4_1791410900.xml","form_type":"4"}},{"id":4637368,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":21219,"kind":"person","name":"HERSHBERG ROBERT","position":1,"cik":"0001274139","reported_name":"HERSHBERG ROBERT","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2026-10-07T22:08:23.000Z","date":"2026-10-06","kind":"sale","planned":true,"acquired":false,"shares":25000,"price":5,"value":125000.0,"ownership":{"direct":true},"balance_after":162156,"source":{"system":"sec-edgar","filing":"0001601830-26-000119","document":"wk-form4_1791410900.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1601830/000160183026000119/wk-form4_1791410900.xml","form_type":"4"}},{"id":4637367,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":21219,"kind":"person","name":"HERSHBERG ROBERT","position":1,"cik":"0001274139","reported_name":"HERSHBERG ROBERT","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2026-10-07T22:08:23.000Z","date":"2026-10-06","kind":"exercise","planned":true,"acquired":true,"shares":25000,"price":2.22,"value":55500.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction is pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 17, 2025."}],"balance_after":187156,"source":{"system":"sec-edgar","filing":"0001601830-26-000119","document":"wk-form4_1791410900.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1601830/000160183026000119/wk-form4_1791410900.xml","form_type":"4"}},{"id":4616192,"issuer":{"id":4289,"kind":"organization","name":"AtaiBeckley Inc.","symbol":"ATAI"},"owners":[{"id":21219,"kind":"person","name":"HERSHBERG ROBERT","position":1,"cik":"0001274139","reported_name":"HERSHBERG ROBERT","relationship":{"director":true}}],"security":"Stock Option","published_at":"2026-09-11T21:44:15.000Z","date":"2026-09-11","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":121968,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"At the effective time of the Merger (the \"Effective Time\"), each outstanding stock option of the Company, subject to certain exceptions, was automatically cancelled and converted into the right to receive (A) an amount in cash (without interest and less applicable tax withholdings) equal to the product of (1) the total number of shares of the Company's common stock subject to such stock option immediately prior to the Effective Time multiplied by (2) the excess of $6.75 over the applicable exercise price per share under such stock option and (B) one contingent value right per share (each, a \"CVR\" and collectively, the \"CVRs\"), representing the right to receive up to an aggregate of $2.50 in cash per CVR upon achievement, if any, of specified clinical and regulatory milestones, less any applicable tax withholding, for each share subject to such stock option immediately prior to the Effective Time (without regard to vesting)."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"At the effective time of the Merger (the \"Effective Time\"), each outstanding stock option of the Company, subject to certain exceptions, was automatically cancelled and converted into the right to receive (A) an amount in cash (without interest and less applicable tax withholdings) equal to the product of (1) the total number of shares of the Company's common stock subject to such stock option immediately prior to the Effective Time multiplied by (2) the excess of $6.75 over the applicable exercise price per share under such stock option and (B) one contingent value right per share (each, a \"CVR\" and collectively, the \"CVRs\"), representing the right to receive up to an aggregate of $2.50 in cash per CVR upon achievement, if any, of specified clinical and regulatory milestones, less any applicable tax withholding, for each share subject to such stock option immediately prior to the Effective Time (without regard to vesting)."}],"balance_after":0,"derivative":{"exercise_price":4.5,"expiration_date":"2036-06-04","underlying":"Common Stock","underlying_shares":121968},"source":{"system":"sec-edgar","filing":"0001140361-26-036379","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/2081043/000114036126036379/form4.xml","form_type":"4"}},{"id":4616191,"issuer":{"id":4289,"kind":"organization","name":"AtaiBeckley Inc.","symbol":"ATAI"},"owners":[{"id":21219,"kind":"person","name":"HERSHBERG ROBERT","position":1,"cik":"0001274139","reported_name":"HERSHBERG ROBERT","relationship":{"director":true}}],"security":"Stock Option","published_at":"2026-09-11T21:44:15.000Z","date":"2026-09-11","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":103000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"At the effective time of the Merger (the \"Effective Time\"), each outstanding stock option of the Company, subject to certain exceptions, was automatically cancelled and converted into the right to receive (A) an amount in cash (without interest and less applicable tax withholdings) equal to the product of (1) the total number of shares of the Company's common stock subject to such stock option immediately prior to the Effective Time multiplied by (2) the excess of $6.75 over the applicable exercise price per share under such stock option and (B) one contingent value right per share (each, a \"CVR\" and collectively, the \"CVRs\"), representing the right to receive up to an aggregate of $2.50 in cash per CVR upon achievement, if any, of specified clinical and regulatory milestones, less any applicable tax withholding, for each share subject to such stock option immediately prior to the Effective Time (without regard to vesting)."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"At the effective time of the Merger (the \"Effective Time\"), each outstanding stock option of the Company, subject to certain exceptions, was automatically cancelled and converted into the right to receive (A) an amount in cash (without interest and less applicable tax withholdings) equal to the product of (1) the total number of shares of the Company's common stock subject to such stock option immediately prior to the Effective Time multiplied by (2) the excess of $6.75 over the applicable exercise price per share under such stock option and (B) one contingent value right per share (each, a \"CVR\" and collectively, the \"CVRs\"), representing the right to receive up to an aggregate of $2.50 in cash per CVR upon achievement, if any, of specified clinical and regulatory milestones, less any applicable tax withholding, for each share subject to such stock option immediately prior to the Effective Time (without regard to vesting)."}],"balance_after":0,"derivative":{"exercise_price":4.48,"expiration_date":"2035-11-05","underlying":"Common Stock","underlying_shares":103000},"source":{"system":"sec-edgar","filing":"0001140361-26-036379","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/2081043/000114036126036379/form4.xml","form_type":"4"}},{"id":4616190,"issuer":{"id":4289,"kind":"organization","name":"AtaiBeckley Inc.","symbol":"ATAI"},"owners":[{"id":21219,"kind":"person","name":"HERSHBERG ROBERT","position":1,"cik":"0001274139","reported_name":"HERSHBERG ROBERT","relationship":{"director":true}}],"security":"Stock Option","published_at":"2026-09-11T21:44:15.000Z","date":"2026-09-11","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":62394,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"At the effective time of the Merger (the \"Effective Time\"), each outstanding stock option of the Company, subject to certain exceptions, was automatically cancelled and converted into the right to receive (A) an amount in cash (without interest and less applicable tax withholdings) equal to the product of (1) the total number of shares of the Company's common stock subject to such stock option immediately prior to the Effective Time multiplied by (2) the excess of $6.75 over the applicable exercise price per share under such stock option and (B) one contingent value right per share (each, a \"CVR\" and collectively, the \"CVRs\"), representing the right to receive up to an aggregate of $2.50 in cash per CVR upon achievement, if any, of specified clinical and regulatory milestones, less any applicable tax withholding, for each share subject to such stock option immediately prior to the Effective Time (without regard to vesting)."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"At the effective time of the Merger (the \"Effective Time\"), each outstanding stock option of the Company, subject to certain exceptions, was automatically cancelled and converted into the right to receive (A) an amount in cash (without interest and less applicable tax withholdings) equal to the product of (1) the total number of shares of the Company's common stock subject to such stock option immediately prior to the Effective Time multiplied by (2) the excess of $6.75 over the applicable exercise price per share under such stock option and (B) one contingent value right per share (each, a \"CVR\" and collectively, the \"CVRs\"), representing the right to receive up to an aggregate of $2.50 in cash per CVR upon achievement, if any, of specified clinical and regulatory milestones, less any applicable tax withholding, for each share subject to such stock option immediately prior to the Effective Time (without regard to vesting)."}],"balance_after":0,"derivative":{"exercise_price":1.35,"expiration_date":"2032-10-20","underlying":"Common Stock","underlying_shares":62394},"source":{"system":"sec-edgar","filing":"0001140361-26-036379","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/2081043/000114036126036379/form4.xml","form_type":"4"}},{"id":4616189,"issuer":{"id":4289,"kind":"organization","name":"AtaiBeckley Inc.","symbol":"ATAI"},"owners":[{"id":21219,"kind":"person","name":"HERSHBERG ROBERT","position":1,"cik":"0001274139","reported_name":"HERSHBERG ROBERT","relationship":{"director":true}}],"security":"Stock Option","published_at":"2026-09-11T21:44:15.000Z","date":"2026-09-11","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":404869,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"At the effective time of the Merger (the \"Effective Time\"), each outstanding stock option of the Company, subject to certain exceptions, was automatically cancelled and converted into the right to receive (A) an amount in cash (without interest and less applicable tax withholdings) equal to the product of (1) the total number of shares of the Company's common stock subject to such stock option immediately prior to the Effective Time multiplied by (2) the excess of $6.75 over the applicable exercise price per share under such stock option and (B) one contingent value right per share (each, a \"CVR\" and collectively, the \"CVRs\"), representing the right to receive up to an aggregate of $2.50 in cash per CVR upon achievement, if any, of specified clinical and regulatory milestones, less any applicable tax withholding, for each share subject to such stock option immediately prior to the Effective Time (without regard to vesting)."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"At the effective time of the Merger (the \"Effective Time\"), each outstanding stock option of the Company, subject to certain exceptions, was automatically cancelled and converted into the right to receive (A) an amount in cash (without interest and less applicable tax withholdings) equal to the product of (1) the total number of shares of the Company's common stock subject to such stock option immediately prior to the Effective Time multiplied by (2) the excess of $6.75 over the applicable exercise price per share under such stock option and (B) one contingent value right per share (each, a \"CVR\" and collectively, the \"CVRs\"), representing the right to receive up to an aggregate of $2.50 in cash per CVR upon achievement, if any, of specified clinical and regulatory milestones, less any applicable tax withholding, for each share subject to such stock option immediately prior to the Effective Time (without regard to vesting)."}],"balance_after":0,"derivative":{"exercise_price":1.35,"expiration_date":"2030-07-08","underlying":"Common Stock","underlying_shares":404869},"source":{"system":"sec-edgar","filing":"0001140361-26-036379","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/2081043/000114036126036379/form4.xml","form_type":"4"}},{"id":4616188,"issuer":{"id":4289,"kind":"organization","name":"AtaiBeckley Inc.","symbol":"ATAI"},"owners":[{"id":21219,"kind":"person","name":"HERSHBERG ROBERT","position":1,"cik":"0001274139","reported_name":"HERSHBERG ROBERT","relationship":{"director":true}}],"security":"Stock Option","published_at":"2026-09-11T21:44:15.000Z","date":"2026-09-11","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":48858,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"At the effective time of the Merger (the \"Effective Time\"), each outstanding stock option of the Company, subject to certain exceptions, was automatically cancelled and converted into the right to receive (A) an amount in cash (without interest and less applicable tax withholdings) equal to the product of (1) the total number of shares of the Company's common stock subject to such stock option immediately prior to the Effective Time multiplied by (2) the excess of $6.75 over the applicable exercise price per share under such stock option and (B) one contingent value right per share (each, a \"CVR\" and collectively, the \"CVRs\"), representing the right to receive up to an aggregate of $2.50 in cash per CVR upon achievement, if any, of specified clinical and regulatory milestones, less any applicable tax withholding, for each share subject to such stock option immediately prior to the Effective Time (without regard to vesting)."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Pursuant to the Agreement and Plan of Merger dated as of July 15, 2026, by and among AtaiBeckley Inc. (the \"Company\"), Eli Lilly and Company, an Indiana corporation (\"Parent\"), and Albali Acquisition Corporation, a Delaware corporation and indirect wholly owned subsidiary of Parent (\"Merger Sub\"), on September 11, 2026, Merger Sub merged with and into the Company (the \"Merger\"), with the Company surviving as a wholly owned subsidiary of Parent."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"At the effective time of the Merger (the \"Effective Time\"), each outstanding stock option of the Company, subject to certain exceptions, was automatically cancelled and converted into the right to receive (A) an amount in cash (without interest and less applicable tax withholdings) equal to the product of (1) the total number of shares of the Company's common stock subject to such stock option immediately prior to the Effective Time multiplied by (2) the excess of $6.75 over the applicable exercise price per share under such stock option and (B) one contingent value right per share (each, a \"CVR\" and collectively, the \"CVRs\"), representing the right to receive up to an aggregate of $2.50 in cash per CVR upon achievement, if any, of specified clinical and regulatory milestones, less any applicable tax withholding, for each share subject to such stock option immediately prior to the Effective Time (without regard to vesting)."}],"balance_after":0,"derivative":{"exercise_price":1.35,"expiration_date":"2030-06-07","underlying":"Common Stock","underlying_shares":48858},"source":{"system":"sec-edgar","filing":"0001140361-26-036379","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2081043/000114036126036379/form4.xml","form_type":"4"}},{"id":679853,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":21219,"kind":"person","name":"HERSHBERG ROBERT","position":1,"cik":"0001274139","reported_name":"HERSHBERG ROBERT","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2026-08-20T21:55:47.000Z","date":"2026-08-18","kind":"exercise","planned":false,"acquired":false,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option was fully vested and exercisable and would have expired on October 18, 2026."}],"balance_after":0,"derivative":{"exercise_price":6.32,"expiration_date":"2026-10-18","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001274139-26-000004","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1478320/000127413926000004/form4.xml","form_type":"4"}},{"id":679852,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":21219,"kind":"person","name":"HERSHBERG ROBERT","position":1,"cik":"0001274139","reported_name":"HERSHBERG ROBERT","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-08-20T21:55:47.000Z","date":"2026-08-18","kind":"sale","planned":false,"acquired":false,"shares":15664,"price":24.41,"value":382358.24,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported for this transaction is a weighted average price. These shares were sold in multiple transactions at prices ranging from $24.40 to $24.44, inclusive. The reporting person undertakes to provide to Adaptive Biotechnologies Corporation, any security holder of Adaptive Biotechnologies Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in any footnotes to this Form 4."}],"balance_after":46683,"source":{"system":"sec-edgar","filing":"0001274139-26-000004","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1478320/000127413926000004/form4.xml","form_type":"4"}},{"id":679851,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":21219,"kind":"person","name":"HERSHBERG ROBERT","position":1,"cik":"0001274139","reported_name":"HERSHBERG ROBERT","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-08-20T21:55:47.000Z","date":"2026-08-18","kind":"sale","planned":false,"acquired":false,"shares":15000,"price":24.39,"value":365850.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported for this transaction is a weighted average price. These shares were sold in multiple transactions at prices ranging from $24.38 to $24.43, inclusive. The reporting person undertakes to provide to Adaptive Biotechnologies Corporation, any security holder of Adaptive Biotechnologies Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in any footnotes to this Form 4."}],"balance_after":62347,"source":{"system":"sec-edgar","filing":"0001274139-26-000004","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1478320/000127413926000004/form4.xml","form_type":"4"}},{"id":679850,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":21219,"kind":"person","name":"HERSHBERG ROBERT","position":1,"cik":"0001274139","reported_name":"HERSHBERG ROBERT","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-08-20T21:55:47.000Z","date":"2026-08-18","kind":"exercise","planned":false,"acquired":true,"shares":15000,"price":6.32,"value":94800.0,"ownership":{"direct":true},"balance_after":77347,"source":{"system":"sec-edgar","filing":"0001274139-26-000004","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1478320/000127413926000004/form4.xml","form_type":"4"}},{"id":712008,"issuer":{"id":4289,"kind":"organization","name":"AtaiBeckley Inc.","symbol":"ATAI"},"owners":[{"id":21219,"kind":"person","name":"HERSHBERG ROBERT","position":1,"cik":"0001274139","reported_name":"HERSHBERG ROBERT","relationship":{"director":true}}],"security":"Stock Option","published_at":"2026-07-09T21:30:27.000Z","date":"2026-07-07","kind":"exercise","planned":true,"acquired":false,"shares":51142,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on April 7, 2026."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The stock option is fully vested."}],"balance_after":404869,"derivative":{"exercise_price":1.35,"expiration_date":"2030-07-08","underlying":"Common Stock","underlying_shares":51142},"source":{"system":"sec-edgar","filing":"0001140361-26-028137","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/2081043/000114036126028137/form4.xml","form_type":"4"}},{"id":712007,"issuer":{"id":4289,"kind":"organization","name":"AtaiBeckley Inc.","symbol":"ATAI"},"owners":[{"id":21219,"kind":"person","name":"HERSHBERG ROBERT","position":1,"cik":"0001274139","reported_name":"HERSHBERG ROBERT","relationship":{"director":true}}],"security":"Stock Option","published_at":"2026-07-09T21:30:27.000Z","date":"2026-07-07","kind":"exercise","planned":true,"acquired":false,"shares":48858,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on April 7, 2026."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The stock option is fully vested."}],"balance_after":48858,"derivative":{"exercise_price":1.35,"expiration_date":"2030-06-08","underlying":"Common Stock","underlying_shares":48858},"source":{"system":"sec-edgar","filing":"0001140361-26-028137","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/2081043/000114036126028137/form4.xml","form_type":"4"}},{"id":712006,"issuer":{"id":4289,"kind":"organization","name":"AtaiBeckley Inc.","symbol":"ATAI"},"owners":[{"id":21219,"kind":"person","name":"HERSHBERG ROBERT","position":1,"cik":"0001274139","reported_name":"HERSHBERG ROBERT","relationship":{"director":true}}],"security":"Common Stock","published_at":"2026-07-09T21:30:27.000Z","date":"2026-07-07","kind":"sale","planned":true,"acquired":false,"shares":100000,"price":4.96,"value":496000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on April 7, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. The securities were sold in multiple transactions at per share prices ranging from $4.90 to $5.08. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price."}],"balance_after":100000,"source":{"system":"sec-edgar","filing":"0001140361-26-028137","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/2081043/000114036126028137/form4.xml","form_type":"4"}},{"id":712005,"issuer":{"id":4289,"kind":"organization","name":"AtaiBeckley Inc.","symbol":"ATAI"},"owners":[{"id":21219,"kind":"person","name":"HERSHBERG ROBERT","position":1,"cik":"0001274139","reported_name":"HERSHBERG ROBERT","relationship":{"director":true}}],"security":"Common Stock","published_at":"2026-07-09T21:30:27.000Z","date":"2026-07-07","kind":"exercise","planned":true,"acquired":true,"shares":51142,"price":1.35,"value":69041.7,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on April 7, 2026."}],"balance_after":100000,"source":{"system":"sec-edgar","filing":"0001140361-26-028137","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/2081043/000114036126028137/form4.xml","form_type":"4"}},{"id":712004,"issuer":{"id":4289,"kind":"organization","name":"AtaiBeckley Inc.","symbol":"ATAI"},"owners":[{"id":21219,"kind":"person","name":"HERSHBERG ROBERT","position":1,"cik":"0001274139","reported_name":"HERSHBERG ROBERT","relationship":{"director":true}}],"security":"Common Stock","published_at":"2026-07-09T21:30:27.000Z","date":"2026-07-07","kind":"exercise","planned":true,"acquired":true,"shares":48858,"price":1.35,"value":65958.3,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on April 7, 2026."}],"balance_after":48858,"source":{"system":"sec-edgar","filing":"0001140361-26-028137","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2081043/000114036126028137/form4.xml","form_type":"4"}},{"id":730221,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":21219,"kind":"person","name":"HERSHBERG ROBERT","position":1,"cik":"0001274139","reported_name":"HERSHBERG ROBERT","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2026-06-22T20:32:34.000Z","date":"2026-06-17","kind":"grant","planned":false,"acquired":true,"shares":88424,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents a grant of restricted stock units automatically granted pursuant to the Issuer's Outside Director Compensation Policy. The restricted stock units will vest on the earlier of June 17,2027 or the day prior to the Issuer's 2027 Annual Meeting of Stockholders, subject to the Reporting Person's continued service to the Issuer."}],"balance_after":162156,"source":{"system":"sec-edgar","filing":"0001601830-26-000087","document":"wk-form4_1782160351.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1274139/000160183026000087/wk-form4_1782160351.xml","form_type":"4"}},{"id":746597,"issuer":{"id":4289,"kind":"organization","name":"AtaiBeckley Inc.","symbol":"ATAI"},"owners":[{"id":21219,"kind":"person","name":"HERSHBERG ROBERT","position":1,"cik":"0001274139","reported_name":"HERSHBERG ROBERT","relationship":{"director":true}}],"security":"Stock Option","published_at":"2026-06-09T00:00:37.000Z","date":"2026-06-04","kind":"grant","planned":false,"acquired":true,"shares":121968,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option shall vest on the earlier of the day before AtaiBeckley Inc.'s next annual meeting or June 4, 2027, subject to continued service on AtaiBeckley Inc.'s board of directors through the applicable vesting date."}],"balance_after":121968,"derivative":{"exercise_price":4.5,"expiration_date":"2036-06-04","underlying":"Common Stock","underlying_shares":121968},"source":{"system":"sec-edgar","filing":"0001140361-26-024524","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2081043/000114036126024524/form4.xml","form_type":"4"}},{"id":855842,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":21219,"kind":"person","name":"HERSHBERG ROBERT","position":1,"cik":"0001274139","reported_name":"HERSHBERG ROBERT","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-03-07T00:49:06.000Z","date":"2026-03-04","kind":"grant","planned":false,"acquired":true,"shares":15625,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":62347,"source":{"system":"sec-edgar","filing":"0001274139-26-000001","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1478320/000127413926000001/primary_doc.xml","form_type":"4"}},{"id":971135,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":21219,"kind":"person","name":"HERSHBERG ROBERT","position":1,"cik":"0001274139","reported_name":"HERSHBERG ROBERT","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-12-13T00:11:10.000Z","date":"2025-12-10","kind":"sale","planned":false,"acquired":false,"shares":22968,"price":16,"value":367488.0,"ownership":{"direct":true},"balance_after":46722,"source":{"system":"sec-edgar","filing":"0001274139-25-000003","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1478320/000127413925000003/primary_doc.xml","form_type":"4"}},{"id":1005659,"issuer":{"id":72536,"kind":"organization","name":"Atai Beckley N.V.","symbol":"ATAI"},"owners":[{"id":21219,"kind":"person","name":"HERSHBERG ROBERT","position":1,"cik":"0001274139","reported_name":"HERSHBERG ROBERT","relationship":{"director":true}}],"security":"Stock Option","published_at":"2025-11-07T01:54:40.000Z","date":"2025-11-05","kind":"grant","planned":false,"acquired":true,"shares":103000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The stock option shall vest in full on the first anniversary of the grant date."}],"balance_after":103000,"derivative":{"exercise_price":4.48,"expiration_date":"2035-11-05","underlying":"Common Shares","underlying_shares":103000},"source":{"system":"sec-edgar","filing":"0001140361-25-040856","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1274139/000114036125040856/form4.xml","form_type":"4"}},{"id":1005658,"issuer":{"id":72536,"kind":"organization","name":"Atai Beckley N.V.","symbol":"ATAI"},"owners":[{"id":21219,"kind":"person","name":"HERSHBERG ROBERT","position":1,"cik":"0001274139","reported_name":"HERSHBERG ROBERT","relationship":{"director":true}}],"security":"Stock Option","published_at":"2025-11-07T01:54:40.000Z","date":"2025-11-05","kind":"grant","planned":false,"acquired":true,"shares":62394,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On November 5, 2025, the Issuer completed its previously announced acquisition of the entire issued share capital of Beckley Psytech Limited (\"Beckley Psytech\") not already owned by the Issuer (the \"Acquisition\") from the shareholders of Beckley Psytech, pursuant to that certain Share Purchase Agreement, dated as of June 2, 2025, by and among the parties thereto, as amended (the \"Purchase Agreement\"). In connection with the Acquisition, the Company acquired all of the issued and outstanding equity interests of Beckley Psytech in exchange for an aggregate of 103,000,066 common shares of the Issuer, issued directly as share consideration or as underlying replacement awards pursuant to the Purchase Agreement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option is fully vested as of the grant date."}],"balance_after":62394,"derivative":{"exercise_price":1.35,"expiration_date":"2032-10-20","underlying":"Common Shares","underlying_shares":62394},"source":{"system":"sec-edgar","filing":"0001140361-25-040856","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1274139/000114036125040856/form4.xml","form_type":"4"}},{"id":1005657,"issuer":{"id":72536,"kind":"organization","name":"Atai Beckley N.V.","symbol":"ATAI"},"owners":[{"id":21219,"kind":"person","name":"HERSHBERG ROBERT","position":1,"cik":"0001274139","reported_name":"HERSHBERG ROBERT","relationship":{"director":true}}],"security":"Stock Option","published_at":"2025-11-07T01:54:40.000Z","date":"2025-11-05","kind":"grant","planned":false,"acquired":true,"shares":97716,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On November 5, 2025, the Issuer completed its previously announced acquisition of the entire issued share capital of Beckley Psytech Limited (\"Beckley Psytech\") not already owned by the Issuer (the \"Acquisition\") from the shareholders of Beckley Psytech, pursuant to that certain Share Purchase Agreement, dated as of June 2, 2025, by and among the parties thereto, as amended (the \"Purchase Agreement\"). In connection with the Acquisition, the Company acquired all of the issued and outstanding equity interests of Beckley Psytech in exchange for an aggregate of 103,000,066 common shares of the Issuer, issued directly as share consideration or as underlying replacement awards pursuant to the Purchase Agreement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option is fully vested as of the grant date."}],"balance_after":97716,"derivative":{"exercise_price":1.35,"expiration_date":"2030-06-07","underlying":"Common Shares","underlying_shares":97716},"source":{"system":"sec-edgar","filing":"0001140361-25-040856","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1274139/000114036125040856/form4.xml","form_type":"4"}},{"id":1005656,"issuer":{"id":72536,"kind":"organization","name":"Atai Beckley N.V.","symbol":"ATAI"},"owners":[{"id":21219,"kind":"person","name":"HERSHBERG ROBERT","position":1,"cik":"0001274139","reported_name":"HERSHBERG ROBERT","relationship":{"director":true}}],"security":"Stock Option","published_at":"2025-11-07T01:54:40.000Z","date":"2025-11-05","kind":"grant","planned":false,"acquired":true,"shares":456011,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On November 5, 2025, the Issuer completed its previously announced acquisition of the entire issued share capital of Beckley Psytech Limited (\"Beckley Psytech\") not already owned by the Issuer (the \"Acquisition\") from the shareholders of Beckley Psytech, pursuant to that certain Share Purchase Agreement, dated as of June 2, 2025, by and among the parties thereto, as amended (the \"Purchase Agreement\"). In connection with the Acquisition, the Company acquired all of the issued and outstanding equity interests of Beckley Psytech in exchange for an aggregate of 103,000,066 common shares of the Issuer, issued directly as share consideration or as underlying replacement awards pursuant to the Purchase Agreement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option is fully vested as of the grant date."}],"balance_after":456011,"derivative":{"exercise_price":1.35,"expiration_date":"2030-07-05","underlying":"Common Shares","underlying_shares":456011},"source":{"system":"sec-edgar","filing":"0001140361-25-040856","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1274139/000114036125040856/form4.xml","form_type":"4"}},{"id":1037389,"issuer":{"id":75097,"kind":"organization","name":"HilleVax, Inc.","symbol":"HLVX"},"owners":[{"id":21219,"kind":"person","name":"HERSHBERG ROBERT","position":1,"cik":"0001274139","reported_name":"HERSHBERG ROBERT","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2025-09-17T20:30:17.000Z","date":"2025-09-17","kind":"other","planned":false,"acquired":false,"shares":1101498,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"In connection with that certain Agreement and Plan of Merger, dated as of August 4, 2025 (the \"Merger Agreement\"), by and among the Issuer, XOMA Royalty Corporation (\"Parent\") and XRA 4 Corp., a wholly owned subsidiary of Parent (\"Merger Sub\" and together with Parent, the \"Purchasers\"), the Purchasers completed a tender offer to acquire all of the issued and outstanding shares of Common Stock of the Issuer in exchange for (a) $1.95 in cash per share (the \"Cash Amount\"), plus (b) one contingent value right (\"CVR\") representing the right to receive certain contingent cash payments equal to the \"CVR Proceeds\" as further described in that certain CVR Agreement entered into between the Purchasers and a representative to the CVR holders. After completion of the tender offer, Merger Sub merged with and into the Issuer, effective as of September 17, 2025 (the \"Effective Time\"), with the Issuer continuing as the surviving corporation and as a wholly owned subsidiary of Parent."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001193125-25-206257","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1274139/000119312525206257/ownership.xml","form_type":"4"}},{"id":1103553,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":21219,"kind":"person","name":"HERSHBERG ROBERT","position":1,"cik":"0001274139","reported_name":"HERSHBERG ROBERT","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-06-23T21:23:23.000Z","date":"2025-06-18","kind":"grant","planned":false,"acquired":true,"shares":44031,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares subject to this option will vest and become exercisable on the earlier of June 18, 2026 or the date of the Issuer's 2026 Annual Meeting of Stockholders, subject to the Reporting Person's continued service to the Issuer."}],"balance_after":44031,"derivative":{"exercise_price":5.11,"expiration_date":"2035-06-18","underlying":"Class A Common Stock","underlying_shares":44031},"source":{"system":"sec-edgar","filing":"0001601830-25-000110","document":"wk-form4_1750713796.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1274139/000160183025000110/wk-form4_1750713796.xml","form_type":"4"}},{"id":1103552,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":21219,"kind":"person","name":"HERSHBERG ROBERT","position":1,"cik":"0001274139","reported_name":"HERSHBERG ROBERT","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2025-06-23T21:23:23.000Z","date":"2025-06-18","kind":"grant","planned":false,"acquired":true,"shares":22016,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents a grant of restricted stock units automatically granted pursuant to the Issuer's Outside Director Compensation Policy. The restricted stock units will vest on the earlier of June 18, 2026 or the day prior to the Issuer's 2026 Annual Meeting of Stockholders, subject to the Reporting Person's continued service to the Issuer."}],"balance_after":73732,"source":{"system":"sec-edgar","filing":"0001601830-25-000110","document":"wk-form4_1750713796.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1274139/000160183025000110/wk-form4_1750713796.xml","form_type":"4"}},{"id":1209546,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":21219,"kind":"person","name":"HERSHBERG ROBERT","position":1,"cik":"0001274139","reported_name":"HERSHBERG ROBERT","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-03-12T23:48:40.000Z","date":"2025-03-12","kind":"sale","planned":false,"acquired":false,"shares":53000,"price":7.59,"value":402270.0,"ownership":{"direct":true},"balance_after":69690,"source":{"system":"sec-edgar","filing":"0001062993-25-005300","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1478320/000106299325005300/form4.xml","form_type":"4"}},{"id":1219461,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":21219,"kind":"person","name":"HERSHBERG ROBERT","position":1,"cik":"0001274139","reported_name":"HERSHBERG ROBERT","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2025-03-07T00:15:16.000Z","date":"2025-03-04","kind":"grant","planned":false,"acquired":true,"shares":23726,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option will vest in equal monthly installments over one year from March 4, 2025, subject to continued service as a director through such vesting dates."}],"balance_after":23726,"derivative":{"exercise_price":8.12,"expiration_date":"2035-03-04","underlying":"Common Stock","underlying_shares":23726},"source":{"system":"sec-edgar","filing":"0001062993-25-004803","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1478320/000106299325004803/form4.xml","form_type":"4"}},{"id":1219460,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":21219,"kind":"person","name":"HERSHBERG ROBERT","position":1,"cik":"0001274139","reported_name":"HERSHBERG ROBERT","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-03-07T00:15:16.000Z","date":"2025-03-04","kind":"grant","planned":false,"acquired":true,"shares":15394,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":122690,"source":{"system":"sec-edgar","filing":"0001062993-25-004803","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1478320/000106299325004803/form4.xml","form_type":"4"}},{"id":1271268,"issuer":{"id":75097,"kind":"organization","name":"HilleVax, Inc.","symbol":"HLVX"},"owners":[{"id":21219,"kind":"person","name":"HERSHBERG ROBERT","position":1,"cik":"0001274139","reported_name":"HERSHBERG ROBERT","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2025-02-12T21:05:07.000Z","date":"2025-02-11","kind":"sale","planned":false,"acquired":false,"shares":11901,"price":1.7648,"value":21002.8848,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"1.\tRepresents shares sold to satisfy tax withholding obligations upon the settlement of restricted stock units (\"RSUs\"), which sale was mandated by the Issuer's election to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary transaction by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"2.\tThe price reported in Column 4 is the weighted average price. These shares were sold in multiple transactions at prices between $1.7551 and $1.7745. The Reporting Person undertakes to provide the Issuer, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":1101498,"source":{"system":"sec-edgar","filing":"0000950170-25-018822","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1274139/000095017025018822/ownership.xml","form_type":"4"}},{"id":1271267,"issuer":{"id":75097,"kind":"organization","name":"HilleVax, Inc.","symbol":"HLVX"},"owners":[{"id":21219,"kind":"person","name":"HERSHBERG ROBERT","position":1,"cik":"0001274139","reported_name":"HERSHBERG ROBERT","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2025-02-12T21:05:07.000Z","date":"2025-02-04","kind":"sale","planned":false,"acquired":false,"shares":14634,"price":1.89,"value":27658.26,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"1.\tRepresents shares sold to satisfy tax withholding obligations upon the settlement of restricted stock units (\"RSUs\"), which sale was mandated by the Issuer's election to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary transaction by the Reporting Person."}],"balance_after":1113399,"source":{"system":"sec-edgar","filing":"0000950170-25-018822","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1274139/000095017025018822/ownership.xml","form_type":"4"}},{"id":1489676,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":21219,"kind":"person","name":"HERSHBERG ROBERT","position":1,"cik":"0001274139","reported_name":"HERSHBERG ROBERT","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-06-05T22:12:17.000Z","date":"2024-06-03","kind":"grant","planned":false,"acquired":true,"shares":26193,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares subject to this option will vest and become exercisable on the earlier of June 3, 2025 or the date of the Issuer's 2025 Annual Meeting of Stockholders, subject to the Reporting Person's continued service to the Issuer."}],"balance_after":26193,"derivative":{"exercise_price":8.59,"expiration_date":"2034-06-03","underlying":"Class A Common Stock","underlying_shares":26193},"source":{"system":"sec-edgar","filing":"0001601830-24-000072","document":"wk-form4_1717625527.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1274139/000160183024000072/wk-form4_1717625527.xml","form_type":"4"}},{"id":1489675,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":21219,"kind":"person","name":"HERSHBERG ROBERT","position":1,"cik":"0001274139","reported_name":"HERSHBERG ROBERT","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2024-06-05T22:12:17.000Z","date":"2024-06-03","kind":"grant","planned":false,"acquired":true,"shares":13097,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents a grant of restricted stock units automatically granted pursuant to the Issuer's Outside Director Compensation Policy. The restricted stock units will vest on the earlier of June 3, 2025 or the day prior to the Issuer's 2025 annual meeting of stockholders, subject to Reporting Person's continued service to the Issuer."}],"balance_after":51716,"source":{"system":"sec-edgar","filing":"0001601830-24-000072","document":"wk-form4_1717625527.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1274139/000160183024000072/wk-form4_1717625527.xml","form_type":"4"}},{"id":1591569,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":21219,"kind":"person","name":"HERSHBERG ROBERT","position":1,"cik":"0001274139","reported_name":"HERSHBERG ROBERT","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-03-07T00:45:02.000Z","date":"2024-03-04","kind":"grant","planned":false,"acquired":true,"shares":48044,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option will vest in equal monthly installments over one year from March 4, 2024, subject to continued service as a director through such vesting dates."}],"balance_after":48044,"derivative":{"exercise_price":3.99,"expiration_date":"2034-03-04","underlying":"Common Stock","underlying_shares":48044},"source":{"system":"sec-edgar","filing":"0001062993-24-005772","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1478320/000106299324005772/form4.xml","form_type":"4"}},{"id":1591568,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":21219,"kind":"person","name":"HERSHBERG ROBERT","position":1,"cik":"0001274139","reported_name":"HERSHBERG ROBERT","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-03-07T00:45:02.000Z","date":"2024-03-04","kind":"grant","planned":false,"acquired":true,"shares":31328,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":107296,"source":{"system":"sec-edgar","filing":"0001062993-24-005772","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1478320/000106299324005772/form4.xml","form_type":"4"}},{"id":1648919,"issuer":{"id":75097,"kind":"organization","name":"HilleVax, Inc.","symbol":"HLVX"},"owners":[{"id":21219,"kind":"person","name":"HERSHBERG ROBERT","position":1,"cik":"0001274139","reported_name":"HERSHBERG ROBERT","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-02-13T00:47:47.000Z","date":"2024-02-08","kind":"grant","planned":false,"acquired":true,"shares":226885,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The option is exercisable as it vests. The option will vest with respect to 25% of the shares of common stock on February 8, 2025 and will vest with respect to the remaining shares in equal monthly installments over the following three years subject to the reporting person's continuous service to the Issuer on the applicable vesting dates."}],"balance_after":226885,"derivative":{"exercise_price":15.06,"expiration_date":"2034-02-07","underlying":"Common Stock","underlying_shares":226885},"source":{"system":"sec-edgar","filing":"0000950170-24-014063","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1274139/000095017024014063/ownership.xml","form_type":"4"}},{"id":1648918,"issuer":{"id":75097,"kind":"organization","name":"HilleVax, Inc.","symbol":"HLVX"},"owners":[{"id":21219,"kind":"person","name":"HERSHBERG ROBERT","position":1,"cik":"0001274139","reported_name":"HERSHBERG ROBERT","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2024-02-13T00:47:47.000Z","date":"2024-02-08","kind":"grant","planned":false,"acquired":true,"shares":174202,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Represents RSUs which will vest as to 25% of the total number of RSUs granted on each of the first four anniversaries of February 8, 2024, subject to the reporting person's continuous service to the Issuer on the applicable vesting dates. Each RSU represents a contingent right to receive one share of common stock of the Issuer and the RSUs have no expiration date."}],"balance_after":1128033,"source":{"system":"sec-edgar","filing":"0000950170-24-014063","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1274139/000095017024014063/ownership.xml","form_type":"4"}},{"id":1648917,"issuer":{"id":75097,"kind":"organization","name":"HilleVax, Inc.","symbol":"HLVX"},"owners":[{"id":21219,"kind":"person","name":"HERSHBERG ROBERT","position":1,"cik":"0001274139","reported_name":"HERSHBERG ROBERT","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2024-02-13T00:47:47.000Z","date":"2024-02-08","kind":"sale","planned":false,"acquired":false,"shares":11597,"price":14.9315,"value":173160.6055,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares sold to satisfy tax withholding obligations upon the settlement of restricted stock units (\"RSUs\"), which sale was mandated by the Issuer's election to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary transaction by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price calculated by the broker executing the sell-to-cover transactions. These shares were sold as part of a block trade in multiple transactions, and the Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate sales price."}],"balance_after":953831,"source":{"system":"sec-edgar","filing":"0000950170-24-014063","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1274139/000095017024014063/ownership.xml","form_type":"4"}},{"id":1847607,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":21219,"kind":"person","name":"HERSHBERG ROBERT","position":1,"cik":"0001274139","reported_name":"HERSHBERG ROBERT","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-06-21T21:20:21.000Z","date":"2023-06-16","kind":"grant","planned":false,"acquired":true,"shares":25224,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"The shares subject to this option will vest and become exercisable on the earlier of June 16, 2024 or the date of the Issuer's 2024 Annual Meeting of Stockholders, subject to the Reporting Person's continued service to the Issuer."}],"balance_after":25224,"derivative":{"exercise_price":8.92,"exercise_date":"2024-06-16","expiration_date":"2033-06-16","underlying":"Class A Common Stock","underlying_shares":25224},"source":{"system":"sec-edgar","filing":"0001209191-23-038840","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1274139/000120919123038840/doc4.xml","form_type":"4"}},{"id":1847606,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":21219,"kind":"person","name":"HERSHBERG ROBERT","position":1,"cik":"0001274139","reported_name":"HERSHBERG ROBERT","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2023-06-21T21:20:21.000Z","date":"2023-06-16","kind":"grant","planned":false,"acquired":true,"shares":12612,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents a grant of restricted stock units automatically granted pursuant to the Issuer's Outside Director Compensation Policy.  The restricted stock units will vest on the earlier of June 16, 2024 or the day prior to the Issuer's 2024 annual meeting of stockholders, subject to Reporting Person's continued service to the Issuer."}],"balance_after":38619,"source":{"system":"sec-edgar","filing":"0001209191-23-038840","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1274139/000120919123038840/doc4.xml","form_type":"4"}},{"id":1863772,"issuer":{"id":5968,"kind":"organization","name":"FATE THERAPEUTICS INC"},"owners":[{"id":21219,"kind":"person","name":"HERSHBERG ROBERT","position":1,"cik":"0001274139","reported_name":"HERSHBERG ROBERT","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-06-07T20:09:21.000Z","date":"2023-06-06","kind":"grant","planned":false,"acquired":true,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction represents a grant of options pursuant to the terms of the Issuer's Amended and Restated Non-Employee Director Compensation Policy which provides for annual equity grants to the Issuer's non-employee directors on the date of the Issuer's Annual Meeting of Stockholders."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares subject to this option shall vest and become exercisable on the earlier of (i) June 6, 2024 or (ii) the date of the Issuer's 2024 Annual Meeting of Stockholders, subject to the Reporting Person's continued service on the Issuer's Board of Directors."}],"balance_after":40000,"derivative":{"exercise_price":5.52,"expiration_date":"2033-06-06","underlying":"Common Stock","underlying_shares":40000},"source":{"system":"sec-edgar","filing":"0001209191-23-035051","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1434316/000120919123035051/doc4.xml","form_type":"4"}},{"id":1963191,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":21219,"kind":"person","name":"HERSHBERG ROBERT","position":1,"cik":"0001274139","reported_name":"HERSHBERG ROBERT","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-03-09T01:06:54.000Z","date":"2023-03-06","kind":"grant","acquired":true,"shares":23329,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option will vest in equal monthly installments over one year from March 4, 2023, subject to continued service as a director through such vesting dates."}],"balance_after":23329,"derivative":{"exercise_price":8.46,"expiration_date":"2033-03-06","underlying":"Common Stock","underlying_shares":23329},"source":{"system":"sec-edgar","filing":"0001062993-23-006334","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1478320/000106299323006334/form4.xml","form_type":"4"}},{"id":1963190,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":21219,"kind":"person","name":"HERSHBERG ROBERT","position":1,"cik":"0001274139","reported_name":"HERSHBERG ROBERT","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-03-09T01:06:54.000Z","date":"2023-03-06","kind":"grant","acquired":true,"shares":14775,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":75968,"source":{"system":"sec-edgar","filing":"0001062993-23-006334","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1478320/000106299323006334/form4.xml","form_type":"4"}},{"id":2032907,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":21219,"kind":"person","name":"HERSHBERG ROBERT","position":1,"cik":"0001274139","reported_name":"HERSHBERG ROBERT","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-02-03T22:00:37.000Z","date":"2023-02-02","kind":"exercise","acquired":false,"shares":53000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option is fully vested and exercisable."}],"balance_after":0,"derivative":{"exercise_price":0.45,"expiration_date":"2023-02-04","underlying":"Common Stock","underlying_shares":53000},"source":{"system":"sec-edgar","filing":"0001209191-23-006994","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1478320/000120919123006994/doc4.xml","form_type":"4"}},{"id":2032906,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":21219,"kind":"person","name":"HERSHBERG ROBERT","position":1,"cik":"0001274139","reported_name":"HERSHBERG ROBERT","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-02-03T22:00:37.000Z","date":"2023-02-02","kind":"exercise","acquired":true,"shares":53000,"price":0.45,"value":23850.0,"ownership":{"direct":true},"balance_after":61193,"source":{"system":"sec-edgar","filing":"0001209191-23-006994","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1478320/000120919123006994/doc4.xml","form_type":"4"}},{"id":2032498,"issuer":{"id":75097,"kind":"organization","name":"HilleVax, Inc.","symbol":"HLVX"},"owners":[{"id":21219,"kind":"person","name":"HERSHBERG ROBERT","position":1,"cik":"0001274139","reported_name":"HERSHBERG ROBERT","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-02-03T21:17:23.000Z","date":"2023-02-01","kind":"grant","acquired":true,"shares":381950,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option is exercisable as it vests. The option will vest with respect to 25% of the shares of common stock on February 1, 2024 and will vest with respect to the remaining shares in equal monthly installments over the following three years subject to the reporting person's continuous service to the Issuer on the applicable vesting dates."}],"balance_after":381950,"derivative":{"exercise_price":18,"expiration_date":"2033-01-31","underlying":"Common Stock","underlying_shares":381950},"source":{"system":"sec-edgar","filing":"0000899243-23-003852","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1274139/000089924323003852/doc4.xml","form_type":"4"}},{"id":2032497,"issuer":{"id":75097,"kind":"organization","name":"HilleVax, Inc.","symbol":"HLVX"},"owners":[{"id":21219,"kind":"person","name":"HERSHBERG ROBERT","position":1,"cik":"0001274139","reported_name":"HERSHBERG ROBERT","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2023-02-03T21:17:23.000Z","date":"2023-02-01","kind":"grant","acquired":true,"shares":187966,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units (\"RSUs\") which will vest as to 25% of the total number of RSUs granted on each of the first four anniversaries of February 1, 2023, subject to the reporting person's continuous service to the Issuer on the applicable vesting dates. Each RSU represents a contingent right to receive one share of common stock of the Issuer and the RSUs have no expiration date."}],"balance_after":965428,"source":{"system":"sec-edgar","filing":"0000899243-23-003852","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1274139/000089924323003852/doc4.xml","form_type":"4"}},{"id":2229659,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":21219,"kind":"person","name":"HERSHBERG ROBERT","position":1,"cik":"0001274139","reported_name":"HERSHBERG ROBERT","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-06-17T00:16:24.000Z","date":"2022-06-14","kind":"grant","acquired":true,"shares":36290,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":36290,"derivative":{"exercise_price":6.2,"exercise_date":"2023-06-14","expiration_date":"2032-06-14","underlying":"Class A Common Stock","underlying_shares":36290},"source":{"system":"sec-edgar","filing":"0001209191-22-037637","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1274139/000120919122037637/doc4.xml","form_type":"4"}},{"id":2229658,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":21219,"kind":"person","name":"HERSHBERG ROBERT","position":1,"cik":"0001274139","reported_name":"HERSHBERG ROBERT","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2022-06-17T00:16:24.000Z","date":"2022-06-14","kind":"grant","acquired":true,"shares":18145,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents a grant of restricted stock units automatically granted pursuant to the Issuer's Outside Director Compensation Policy.  The restricted stock units will vest on the earlier of June 14, 2023 or the day prior to the Issuer's 2023 annual meeting of stockholders."}],"balance_after":26007,"source":{"system":"sec-edgar","filing":"0001209191-22-037637","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1274139/000120919122037637/doc4.xml","form_type":"4"}},{"id":2234178,"issuer":{"id":883,"kind":"organization","name":"ARS Pharmaceuticals, Inc.","symbol":"SPRY"},"owners":[{"id":21219,"kind":"person","name":"HERSHBERG ROBERT","position":1,"cik":"0001274139","reported_name":"HERSHBERG ROBERT","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-06-13T23:31:19.000Z","date":"2022-06-10","kind":"grant","acquired":true,"shares":18000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option vest on the earlier of June 10, 2023 or the date of the Issuer's 2023 annual meeting of stockholders, which date has not been set by the Issuer's Board of Directors."}],"balance_after":18000,"derivative":{"exercise_price":4.18,"expiration_date":"2032-06-09","underlying":"Common Stock","underlying_shares":18000},"source":{"system":"sec-edgar","filing":"0001209191-22-036472","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1671858/000120919122036472/doc4.xml","form_type":"4"}},{"id":2234033,"issuer":{"id":5968,"kind":"organization","name":"FATE THERAPEUTICS INC"},"owners":[{"id":21219,"kind":"person","name":"HERSHBERG ROBERT","position":1,"cik":"0001274139","reported_name":"HERSHBERG ROBERT","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-06-13T20:41:12.000Z","date":"2022-06-09","kind":"grant","acquired":true,"shares":11893,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares subject to this option shall vest and become exercisable on the earlier of (i) June 9, 2023 or (ii) the date of the Issuer's 2023 Annual Meeting of Stockholders, subject to the Reporting Person's continued service on the Issuer's Board of Directors."}],"balance_after":11893,"derivative":{"exercise_price":23.48,"expiration_date":"2032-06-09","underlying":"Common Stock","underlying_shares":11893},"source":{"system":"sec-edgar","filing":"0001209191-22-036347","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1434316/000120919122036347/doc4.xml","form_type":"4"}},{"id":2234032,"issuer":{"id":5968,"kind":"organization","name":"FATE THERAPEUTICS INC"},"owners":[{"id":21219,"kind":"person","name":"HERSHBERG ROBERT","position":1,"cik":"0001274139","reported_name":"HERSHBERG ROBERT","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-06-13T20:41:12.000Z","date":"2022-06-09","kind":"grant","acquired":true,"shares":8650,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Award of restricted stock units that vest in full on the earlier of (i) June 9, 2023 or (ii) the date of the Issuer's 2023 Annual Meeting of Stockholders, subject to the Reporting Person's continued service on the Issuer's Board of Directors."}],"balance_after":10659,"source":{"system":"sec-edgar","filing":"0001209191-22-036347","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1434316/000120919122036347/doc4.xml","form_type":"4"}},{"id":2242203,"issuer":{"id":5968,"kind":"organization","name":"FATE THERAPEUTICS INC"},"owners":[{"id":21219,"kind":"person","name":"HERSHBERG ROBERT","position":1,"cik":"0001274139","reported_name":"HERSHBERG ROBERT","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-06-06T20:45:54.000Z","date":"2022-06-03","kind":"sale","acquired":false,"shares":672,"price":22.75,"value":15288.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Required number of shares sold by the reporting person to cover tax obligations in connection with the vesting of 2,681 shares of Common Stock underlying RSUs granted to the reporting person on June 2, 2021. This sale was made pursuant to an irrevocable election by the reporting person to satisfy tax obligations through a \"sell to cover\" transaction and does not represent a discretionary trade by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the weighted average sale price of the shares sold from $22.53 to $22.86 per share. The Reporting Person will provide, upon request\nby the Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price\nwithin the ranges set forth in footnote 2."}],"balance_after":2009,"source":{"system":"sec-edgar","filing":"0001209191-22-034546","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1434316/000120919122034546/doc4.xml","form_type":"4"}},{"id":2295622,"issuer":{"id":15988,"kind":"organization","name":"NanoString Technologies Inc","symbol":"NSTG"},"owners":[{"id":21219,"kind":"person","name":"HERSHBERG ROBERT","position":1,"cik":"0001274139","reported_name":"HERSHBERG ROBERT","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-04-18T20:27:19.000Z","date":"2022-04-18","kind":"exercise","acquired":false,"shares":3306,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one (1) share of Issuer's common stock."},{"field":"kind","element":"transactionCoding","label":"F2","text":"In recognition of his service to the Board of Directors of the Issuer, Dr. Hershberg's non-vested RSU awards were partially accelerated effective April 18, 2022 immediately prior to the effectiveness of his resignation as a member of the Board of Directors."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"100% of the RSUs vest on the earlier of the one year anniversary of June 16, 2021 or on the date immediately prior to the 2022 annual meeting of stockholders."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"100% of the RSUs vest on the earlier of the one year anniversary of June 16, 2021 or on the date immediately prior to the 2022 annual meeting of stockholders."}],"balance_after":584,"derivative":{"underlying":"Common Stock","underlying_shares":3306},"source":{"system":"sec-edgar","filing":"0001401708-22-000083","document":"wf-form4_165032802529060.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1401708/000140170822000083/wf-form4_165032802529060.xml","form_type":"4"}},{"id":2295621,"issuer":{"id":15988,"kind":"organization","name":"NanoString Technologies Inc","symbol":"NSTG"},"owners":[{"id":21219,"kind":"person","name":"HERSHBERG ROBERT","position":1,"cik":"0001274139","reported_name":"HERSHBERG ROBERT","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-04-18T20:27:19.000Z","date":"2022-04-18","kind":"exercise","acquired":true,"shares":3306,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one (1) share of Issuer's common stock."}],"balance_after":10716,"source":{"system":"sec-edgar","filing":"0001401708-22-000083","document":"wf-form4_165032802529060.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1401708/000140170822000083/wf-form4_165032802529060.xml","form_type":"4"}},{"id":2422472,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":21219,"kind":"person","name":"HERSHBERG ROBERT","position":1,"cik":"0001274139","reported_name":"HERSHBERG ROBERT","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-01-29T00:00:27.000Z","date":"2022-01-26","kind":"grant","acquired":true,"shares":16722,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option will vest in equal monthly installments over one year, subject to continued service as a director through such vesting date."}],"balance_after":16722,"derivative":{"exercise_price":14.95,"expiration_date":"2032-01-26","underlying":"Common Stock","underlying_shares":16722},"source":{"system":"sec-edgar","filing":"0001209191-22-005496","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1478320/000120919122005496/doc4.xml","form_type":"4"}},{"id":2422471,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":21219,"kind":"person","name":"HERSHBERG ROBERT","position":1,"cik":"0001274139","reported_name":"HERSHBERG ROBERT","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-01-29T00:00:27.000Z","date":"2022-01-26","kind":"grant","acquired":true,"shares":6689,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":8193,"source":{"system":"sec-edgar","filing":"0001209191-22-005496","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1478320/000120919122005496/doc4.xml","form_type":"4"}},{"id":2443204,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":21219,"kind":"person","name":"HERSHBERG ROBERT","position":1,"cik":"0001274139","reported_name":"HERSHBERG ROBERT","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2022-01-06T01:45:09.000Z","date":"2022-01-03","kind":"grant","acquired":true,"shares":693,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares were issued pursuant to the Issuer's Outside Director Compensation Policy."}],"balance_after":7862,"source":{"system":"sec-edgar","filing":"0001209191-22-002056","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1274139/000120919122002056/doc4.xml","form_type":"4"}},{"id":2548379,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":21219,"kind":"person","name":"HERSHBERG ROBERT","position":1,"cik":"0001274139","reported_name":"HERSHBERG ROBERT","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2021-10-06T00:31:58.000Z","date":"2021-10-01","kind":"grant","acquired":true,"shares":572,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares were issued pursuant to the Issuer's Outside Director Compensation Policy."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The shares were issued pursuant to the Issuer's Outside Director Compensation Policy."}],"balance_after":7169,"source":{"system":"sec-edgar","filing":"0001209191-21-059743","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1274139/000120919121059743/doc4.xml","form_type":"4"}},{"id":2563083,"issuer":{"id":883,"kind":"organization","name":"ARS Pharmaceuticals, Inc.","symbol":"SPRY"},"owners":[{"id":21219,"kind":"person","name":"HERSHBERG ROBERT","position":1,"cik":"0001274139","reported_name":"HERSHBERG ROBERT","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2021-09-21T21:04:59.000Z","date":"2021-06-04","kind":"grant","acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option vest on the earlier of June 4, 2022 or the date of the 2022 annual meeting of the Issuer's stockholders which date has not been set by the Issuer's Board of Directors."}],"balance_after":15000,"derivative":{"exercise_price":28.83,"expiration_date":"2031-06-03","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001209191-21-057057","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1671858/000120919121057057/doc4.xml","form_type":"4"}},{"id":2640746,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":21219,"kind":"person","name":"HERSHBERG ROBERT","position":1,"cik":"0001274139","reported_name":"HERSHBERG ROBERT","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2021-07-06T21:01:20.000Z","date":"2021-07-01","kind":"grant","acquired":true,"shares":347,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares were issued pursuant to the Issuer's Outside Director Compensation Policy."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The shares were issued pursuant to the Issuer's Outside Director Compensation Policy."}],"balance_after":6597,"source":{"system":"sec-edgar","filing":"0001209191-21-045555","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1274139/000120919121045555/doc4.xml","form_type":"4"}},{"id":2663404,"issuer":{"id":15988,"kind":"organization","name":"NanoString Technologies Inc","symbol":"NSTG"},"owners":[{"id":21219,"kind":"person","name":"HERSHBERG ROBERT","position":1,"cik":"0001274139","reported_name":"HERSHBERG ROBERT","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-06-17T19:00:46.000Z","date":"2021-06-16","kind":"grant","acquired":true,"shares":3890,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one (1) share of Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"100% of the RSUs vest on the earlier of the one year anniversary of June 16, 2021 or on the date immediately prior to the 2022 annual meeting of stockholders."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"100% of the RSUs vest on the earlier of the one year anniversary of June 16, 2021 or on the date immediately prior to the 2022 annual meeting of stockholders."}],"balance_after":3890,"derivative":{"underlying":"Common Stock","underlying_shares":3890},"source":{"system":"sec-edgar","filing":"0001401708-21-000175","document":"wf-form4_162397076985129.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1401708/000140170821000175/wf-form4_162397076985129.xml","form_type":"4"}},{"id":2663403,"issuer":{"id":15988,"kind":"organization","name":"NanoString Technologies Inc","symbol":"NSTG"},"owners":[{"id":21219,"kind":"person","name":"HERSHBERG ROBERT","position":1,"cik":"0001274139","reported_name":"HERSHBERG ROBERT","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-06-17T19:00:46.000Z","date":"2021-06-15","kind":"exercise","acquired":false,"shares":5520,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one (1) share of Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"100% of the RSUs vest on the earlier of the one year anniversary of June 16, 2020 or on the date immediately prior to the 2021 annual meeting of stockholders."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"100% of the RSUs vest on the earlier of the one year anniversary of June 16, 2020 or on the date immediately prior to the 2021 annual meeting of stockholders."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":5520},"source":{"system":"sec-edgar","filing":"0001401708-21-000175","document":"wf-form4_162397076985129.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1401708/000140170821000175/wf-form4_162397076985129.xml","form_type":"4"}},{"id":2663402,"issuer":{"id":15988,"kind":"organization","name":"NanoString Technologies Inc","symbol":"NSTG"},"owners":[{"id":21219,"kind":"person","name":"HERSHBERG ROBERT","position":1,"cik":"0001274139","reported_name":"HERSHBERG ROBERT","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-06-17T19:00:46.000Z","date":"2021-06-15","kind":"exercise","acquired":true,"shares":5520,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one (1) share of Issuer's common stock."}],"balance_after":7410,"source":{"system":"sec-edgar","filing":"0001401708-21-000175","document":"wf-form4_162397076985129.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1401708/000140170821000175/wf-form4_162397076985129.xml","form_type":"4"}},{"id":2680823,"issuer":{"id":5968,"kind":"organization","name":"FATE THERAPEUTICS INC"},"owners":[{"id":21219,"kind":"person","name":"HERSHBERG ROBERT","position":1,"cik":"0001274139","reported_name":"HERSHBERG ROBERT","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-06-04T21:33:35.000Z","date":"2021-06-02","kind":"grant","acquired":true,"shares":4334,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares subject to this option shall vest and become exercisable on the earlier of (i) June 2, 2022 or (ii) the date of the Issuer's 2022 Annual Meeting of Stockholders, subject to the Reporting Person's continued service on the Issuer's Board of Directors."}],"balance_after":4334,"derivative":{"exercise_price":68.94,"expiration_date":"2031-06-01","underlying":"Common Stock","underlying_shares":4334},"source":{"system":"sec-edgar","filing":"0000899243-21-022091","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1434316/000089924321022091/doc4.xml","form_type":"4"}},{"id":2680822,"issuer":{"id":5968,"kind":"organization","name":"FATE THERAPEUTICS INC"},"owners":[{"id":21219,"kind":"person","name":"HERSHBERG ROBERT","position":1,"cik":"0001274139","reported_name":"HERSHBERG ROBERT","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-06-04T21:33:35.000Z","date":"2021-06-02","kind":"grant","acquired":true,"shares":2681,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Award of restricted stock units that vest in full on the earlier of (i) June 2, 2022 or (ii) the date of the Issuer's 2022 Annual Meeting of Stockholders, subject to the Reporting Person's continued service on the Issuer's Board of Directors."}],"balance_after":2681,"source":{"system":"sec-edgar","filing":"0000899243-21-022091","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1434316/000089924321022091/doc4.xml","form_type":"4"}},{"id":2741799,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":21219,"kind":"person","name":"HERSHBERG ROBERT","position":1,"cik":"0001274139","reported_name":"HERSHBERG ROBERT","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-04-22T23:59:52.000Z","date":"2021-04-20","kind":"exercise","acquired":true,"shares":525000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"One forty-eighth (1/48th) of the shares subject to the award shall vest one month after March 16, 2020, or the Vesting Commencement Date, and one forty-eighth (1/48th) of the shares subject to the award shall vest each month thereafter on the same day of the month as the Vesting Commencement Date."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"Immediately prior to the completion of the Issuer's initial public offering of Class A Common Stock, each share of Common Stock shall be reclassified into one share of Class A Common Stock."}],"balance_after":525000,"derivative":{"exercise_price":2.22,"expiration_date":"2030-03-19","underlying":"Class A Common Stock","underlying_shares":525000},"source":{"system":"sec-edgar","filing":"0001209191-21-028032","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1274139/000120919121028032/doc4.xml","form_type":"4"}},{"id":2741798,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":21219,"kind":"person","name":"HERSHBERG ROBERT","position":1,"cik":"0001274139","reported_name":"HERSHBERG ROBERT","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-04-22T23:59:52.000Z","date":"2021-04-20","kind":"exercise","acquired":false,"shares":525000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"One forty-eighth (1/48th) of the shares subject to the award shall vest one month after March 16, 2020, or the Vesting Commencement Date, and one forty-eighth (1/48th) of the shares subject to the award shall vest each month thereafter on the same day of the month as the Vesting Commencement Date."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"Immediately prior to the completion of the Issuer's initial public offering of Class A Common Stock, each share of Common Stock shall be reclassified into one share of Class A Common Stock."}],"balance_after":0,"derivative":{"exercise_price":2.22,"expiration_date":"2030-03-19","underlying":"Common Stock","underlying_shares":525000},"source":{"system":"sec-edgar","filing":"0001209191-21-028032","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1274139/000120919121028032/doc4.xml","form_type":"4"}},{"id":2741797,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":21219,"kind":"person","name":"HERSHBERG ROBERT","position":1,"cik":"0001274139","reported_name":"HERSHBERG ROBERT","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-04-22T23:59:52.000Z","date":"2021-04-20","kind":"exercise","acquired":true,"shares":12500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option becomes exercisable upon the earlier of April 15, 2022 or the date of the Issuer's first annual meeting of stockholders."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"Immediately prior to the completion of the Issuer's initial public offering of Class A Common Stock, each share of Common Stock shall be reclassified into one share of Class A Common Stock."}],"balance_after":12500,"derivative":{"exercise_price":18,"expiration_date":"2031-04-14","underlying":"Class A Common Stock","underlying_shares":12500},"source":{"system":"sec-edgar","filing":"0001209191-21-028032","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1274139/000120919121028032/doc4.xml","form_type":"4"}},{"id":2741796,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":21219,"kind":"person","name":"HERSHBERG ROBERT","position":1,"cik":"0001274139","reported_name":"HERSHBERG ROBERT","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-04-22T23:59:52.000Z","date":"2021-04-20","kind":"exercise","acquired":false,"shares":12500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option becomes exercisable upon the earlier of April 15, 2022 or the date of the Issuer's first annual meeting of stockholders."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"Immediately prior to the completion of the Issuer's initial public offering of Class A Common Stock, each share of Common Stock shall be reclassified into one share of Class A Common Stock."}],"balance_after":0,"derivative":{"exercise_price":18,"expiration_date":"2031-04-14","underlying":"Common Stock","underlying_shares":12500},"source":{"system":"sec-edgar","filing":"0001209191-21-028032","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1274139/000120919121028032/doc4.xml","form_type":"4"}},{"id":2741795,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":21219,"kind":"person","name":"HERSHBERG ROBERT","position":1,"cik":"0001274139","reported_name":"HERSHBERG ROBERT","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2021-04-22T23:59:52.000Z","date":"2021-04-20","kind":"exercise","acquired":true,"shares":6250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"The shares are represented by restricted stock units (\"RSUs\"). Each RSU represents the Reporting Person's right to receive one share of common stock of the Issuer, with all such shares being received on the earlier of April 16, 2022 or the Issuer's first annual meeting of stockholders.  In the event the Reporting Person ceases to be a service provider to the Issuer, the unvested RSUs will be cancelled by the Issuer."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Immediately prior to the completion of the Issuer's initial public offering of Class A Common Stock, each share of Common Stock shall be reclassified into one share of Class A Common Stock."}],"balance_after":6250,"source":{"system":"sec-edgar","filing":"0001209191-21-028032","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1274139/000120919121028032/doc4.xml","form_type":"4"}},{"id":2741794,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":21219,"kind":"person","name":"HERSHBERG ROBERT","position":1,"cik":"0001274139","reported_name":"HERSHBERG ROBERT","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-04-22T23:59:52.000Z","date":"2021-04-20","kind":"exercise","acquired":false,"shares":6250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Immediately prior to the completion of the Issuer's initial public offering of Class A Common Stock, each share of Common Stock shall be reclassified into one share of Class A Common Stock."},{"field":"shares","element":"transactionShares","label":"F2","text":"The shares are represented by restricted stock units (\"RSUs\"). Each RSU represents the Reporting Person's right to receive one share of common stock of the Issuer, with all such shares being received on the earlier of April 16, 2022 or the Issuer's first annual meeting of stockholders.  In the event the Reporting Person ceases to be a service provider to the Issuer, the unvested RSUs will be cancelled by the Issuer."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Immediately prior to the completion of the Issuer's initial public offering of Class A Common Stock, each share of Common Stock shall be reclassified into one share of Class A Common Stock."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001209191-21-028032","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1274139/000120919121028032/doc4.xml","form_type":"4"}},{"id":2744867,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":21219,"kind":"person","name":"HERSHBERG ROBERT","position":1,"cik":"0001274139","reported_name":"HERSHBERG ROBERT","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-04-19T23:27:16.000Z","date":"2021-04-15","kind":"grant","acquired":true,"shares":12500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option becomes exercisable upon the earlier of April 15, 2022 or the date of the Issuer's first annual meeting of stockholders."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"Immediately prior to the completion of the Issuer's initial public offering of Class A Common Stock, each share of Common Stock shall be reclassified into one share of Class A Common Stock."}],"balance_after":12500,"derivative":{"exercise_price":18,"expiration_date":"2031-04-14","underlying":"Common Stock","underlying_shares":12500},"source":{"system":"sec-edgar","filing":"0001209191-21-027402","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1274139/000120919121027402/doc4.xml","form_type":"4"}},{"id":2744866,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":21219,"kind":"person","name":"HERSHBERG ROBERT","position":1,"cik":"0001274139","reported_name":"HERSHBERG ROBERT","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-04-19T23:27:16.000Z","date":"2021-04-16","kind":"grant","acquired":true,"shares":6250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Immediately prior to the completion of the Issuer's initial public offering of Class A Common Stock, each share of Common Stock shall be reclassified into one share of Class A Common Stock."},{"field":"shares","element":"transactionShares","label":"F2","text":"The shares are represented by restricted stock units (\"RSUs\"). Each RSU represents the Reporting Person's right to receive one share of common stock of the Issuer, with all such shares being received on the earlier of April 16, 2022 or the Issuer's first annual meeting of stockholders.  In the event the Reporting Person ceases to be a service provider to the Issuer, the unvested RSUs will be cancelled by the Issuer."}],"balance_after":6250,"source":{"system":"sec-edgar","filing":"0001209191-21-027402","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1274139/000120919121027402/doc4.xml","form_type":"4"}},{"id":2744950,"issuer":{"id":15988,"kind":"organization","name":"NanoString Technologies Inc","symbol":"NSTG"},"owners":[{"id":21219,"kind":"person","name":"HERSHBERG ROBERT","position":1,"cik":"0001274139","reported_name":"HERSHBERG ROBERT","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2021-04-19T16:17:35.000Z","date":"2021-04-15","kind":"exercise","acquired":false,"shares":144,"price":14.71,"value":2118.24,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"100% of the shares subject to the Option vest on the one year anniversary of January 1, 2016. The vesting of shares subject to the Option will accelerate in full upon a \"change in control\" as defined in the 2013 Equity Incentive Plan."}],"balance_after":7684,"derivative":{"exercise_price":14.71,"expiration_date":"2025-12-31","underlying":"Common Stock","underlying_shares":144},"source":{"system":"sec-edgar","filing":"0001401708-21-000125","document":"wf-form4_161886343330491.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1401708/000140170821000125/wf-form4_161886343330491.xml","form_type":"4"}},{"id":2744949,"issuer":{"id":15988,"kind":"organization","name":"NanoString Technologies Inc","symbol":"NSTG"},"owners":[{"id":21219,"kind":"person","name":"HERSHBERG ROBERT","position":1,"cik":"0001274139","reported_name":"HERSHBERG ROBERT","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-04-19T16:17:35.000Z","date":"2021-04-15","kind":"sale","acquired":false,"shares":118,"price":74.2,"value":8755.6,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported by Dr. Hershberg were effected pursuant to a Rule 10b5-1 trading plan adopted on March 15, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The \"Amount\" and \"Price\" reported in this Column 4 reflect the aggregate number and weighted-average price, respectively, of shares sold. These shares were sold in multiple transactions at prices ranging from $73.75 to $74.68, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein."}],"balance_after":1890,"source":{"system":"sec-edgar","filing":"0001401708-21-000125","document":"wf-form4_161886343330491.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1401708/000140170821000125/wf-form4_161886343330491.xml","form_type":"4"}},{"id":2744948,"issuer":{"id":15988,"kind":"organization","name":"NanoString Technologies Inc","symbol":"NSTG"},"owners":[{"id":21219,"kind":"person","name":"HERSHBERG ROBERT","position":1,"cik":"0001274139","reported_name":"HERSHBERG ROBERT","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-04-19T16:17:35.000Z","date":"2021-04-15","kind":"sale","acquired":false,"shares":19,"price":72.87,"value":1384.53,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported by Dr. Hershberg were effected pursuant to a Rule 10b5-1 trading plan adopted on March 15, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The \"Amount\" and \"Price\" reported in this Column 4 reflect the aggregate number and weighted-average price, respectively, of shares sold. These shares were sold in multiple transactions at prices ranging from $72.70 to $73.165, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein."}],"balance_after":2008,"source":{"system":"sec-edgar","filing":"0001401708-21-000125","document":"wf-form4_161886343330491.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1401708/000140170821000125/wf-form4_161886343330491.xml","form_type":"4"}},{"id":2744947,"issuer":{"id":15988,"kind":"organization","name":"NanoString Technologies Inc","symbol":"NSTG"},"owners":[{"id":21219,"kind":"person","name":"HERSHBERG ROBERT","position":1,"cik":"0001274139","reported_name":"HERSHBERG ROBERT","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-04-19T16:17:35.000Z","date":"2021-04-15","kind":"sale","acquired":false,"shares":7,"price":71.75,"value":502.25,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported by Dr. Hershberg were effected pursuant to a Rule 10b5-1 trading plan adopted on March 15, 2020."}],"balance_after":2027,"source":{"system":"sec-edgar","filing":"0001401708-21-000125","document":"wf-form4_161886343330491.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1401708/000140170821000125/wf-form4_161886343330491.xml","form_type":"4"}},{"id":2744946,"issuer":{"id":15988,"kind":"organization","name":"NanoString Technologies Inc","symbol":"NSTG"},"owners":[{"id":21219,"kind":"person","name":"HERSHBERG ROBERT","position":1,"cik":"0001274139","reported_name":"HERSHBERG ROBERT","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-04-19T16:17:35.000Z","date":"2021-04-15","kind":"exercise","acquired":true,"shares":144,"price":14.71,"value":2118.24,"ownership":{"direct":true},"balance_after":2034,"source":{"system":"sec-edgar","filing":"0001401708-21-000125","document":"wf-form4_161886343330491.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1401708/000140170821000125/wf-form4_161886343330491.xml","form_type":"4"}},{"id":2781798,"issuer":{"id":15988,"kind":"organization","name":"NanoString Technologies Inc","symbol":"NSTG"},"owners":[{"id":21219,"kind":"person","name":"HERSHBERG ROBERT","position":1,"cik":"0001274139","reported_name":"HERSHBERG ROBERT","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2021-03-17T16:25:48.000Z","date":"2021-03-15","kind":"exercise","acquired":false,"shares":1500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"50% of the shares subject to the Option vest on the one year anniversary of March 2, 2015 (the \"Vesting Commencement Date\") and thereafter the remaining 50% of the total shares vest in twelve equal monthly installments on each monthly anniversary of the Vesting Commencement Date, subject to continued service as a director through each vesting date."}],"balance_after":0,"derivative":{"exercise_price":11.2,"expiration_date":"2025-03-01","underlying":"Common Stock","underlying_shares":1500},"source":{"system":"sec-edgar","filing":"0001401708-21-000076","document":"wf-form4_161601271737509.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1401708/000140170821000076/wf-form4_161601271737509.xml","form_type":"4"}},{"id":2781797,"issuer":{"id":15988,"kind":"organization","name":"NanoString Technologies Inc","symbol":"NSTG"},"owners":[{"id":21219,"kind":"person","name":"HERSHBERG ROBERT","position":1,"cik":"0001274139","reported_name":"HERSHBERG ROBERT","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-03-17T16:25:48.000Z","date":"2021-03-15","kind":"sale","acquired":false,"shares":1214,"price":67.16,"value":81532.24,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported by Dr. Hershberg were effected pursuant to a Rule 10b5-1 trading plan adopted on March 15, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The \"Amount\" and \"Price\" reported in this Column 4 reflect the aggregate number and weighted-average price, respectively, of shares sold. These shares were sold in multiple transactions at prices ranging from $66.63 to $67.58, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein."}],"balance_after":1890,"source":{"system":"sec-edgar","filing":"0001401708-21-000076","document":"wf-form4_161601271737509.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1401708/000140170821000076/wf-form4_161601271737509.xml","form_type":"4"}},{"id":2781796,"issuer":{"id":15988,"kind":"organization","name":"NanoString Technologies Inc","symbol":"NSTG"},"owners":[{"id":21219,"kind":"person","name":"HERSHBERG ROBERT","position":1,"cik":"0001274139","reported_name":"HERSHBERG ROBERT","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-03-17T16:25:48.000Z","date":"2021-03-15","kind":"sale","acquired":false,"shares":282,"price":66.03,"value":18620.46,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported by Dr. Hershberg were effected pursuant to a Rule 10b5-1 trading plan adopted on March 15, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The \"Amount\" and \"Price\" reported in this Column 4 reflect the aggregate number and weighted-average price, respectively, of shares sold. These shares were sold in multiple transactions at prices ranging from $65.62 to $66.30, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein."}],"balance_after":3104,"source":{"system":"sec-edgar","filing":"0001401708-21-000076","document":"wf-form4_161601271737509.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1401708/000140170821000076/wf-form4_161601271737509.xml","form_type":"4"}},{"id":2781795,"issuer":{"id":15988,"kind":"organization","name":"NanoString Technologies Inc","symbol":"NSTG"},"owners":[{"id":21219,"kind":"person","name":"HERSHBERG ROBERT","position":1,"cik":"0001274139","reported_name":"HERSHBERG ROBERT","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-03-17T16:25:48.000Z","date":"2021-03-15","kind":"sale","acquired":false,"shares":4,"price":63.58,"value":254.32,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported by Dr. Hershberg were effected pursuant to a Rule 10b5-1 trading plan adopted on March 15, 2020."}],"balance_after":3386,"source":{"system":"sec-edgar","filing":"0001401708-21-000076","document":"wf-form4_161601271737509.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1401708/000140170821000076/wf-form4_161601271737509.xml","form_type":"4"}},{"id":2781794,"issuer":{"id":15988,"kind":"organization","name":"NanoString Technologies Inc","symbol":"NSTG"},"owners":[{"id":21219,"kind":"person","name":"HERSHBERG ROBERT","position":1,"cik":"0001274139","reported_name":"HERSHBERG ROBERT","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-03-17T16:25:48.000Z","date":"2021-03-15","kind":"exercise","acquired":true,"shares":1500,"price":11.2,"value":16800.0,"ownership":{"direct":true},"balance_after":3390,"source":{"system":"sec-edgar","filing":"0001401708-21-000076","document":"wf-form4_161601271737509.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1401708/000140170821000076/wf-form4_161601271737509.xml","form_type":"4"}},{"id":2796877,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":21219,"kind":"person","name":"HERSHBERG ROBERT","position":1,"cik":"0001274139","reported_name":"HERSHBERG ROBERT","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-03-11T00:00:18.000Z","date":"2021-03-08","kind":"exercise","acquired":false,"shares":2000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 13, 2020."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option is fully vested and exercisable."}],"balance_after":53000,"derivative":{"exercise_price":0.45,"expiration_date":"2023-02-04","underlying":"Common Stock","underlying_shares":2000},"source":{"system":"sec-edgar","filing":"0001209191-21-019620","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1478320/000120919121019620/doc4.xml","form_type":"4"}},{"id":2796876,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":21219,"kind":"person","name":"HERSHBERG ROBERT","position":1,"cik":"0001274139","reported_name":"HERSHBERG ROBERT","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-03-11T00:00:18.000Z","date":"2021-03-08","kind":"sale","acquired":false,"shares":2000,"price":44.56,"value":89120.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 13, 2020."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001209191-21-019620","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1478320/000120919121019620/doc4.xml","form_type":"4"}},{"id":2796875,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":21219,"kind":"person","name":"HERSHBERG ROBERT","position":1,"cik":"0001274139","reported_name":"HERSHBERG ROBERT","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-03-11T00:00:18.000Z","date":"2021-03-08","kind":"exercise","acquired":true,"shares":2000,"price":0.45,"value":900.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 13, 2020."}],"balance_after":2000,"source":{"system":"sec-edgar","filing":"0001209191-21-019620","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1478320/000120919121019620/doc4.xml","form_type":"4"}},{"id":2796874,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":21219,"kind":"person","name":"HERSHBERG ROBERT","position":1,"cik":"0001274139","reported_name":"HERSHBERG ROBERT","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-03-11T00:00:14.000Z","date":"2021-03-08","kind":"exercise","acquired":false,"shares":2000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 13, 2020."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option is fully vested and exercisable."}],"balance_after":53000,"derivative":{"exercise_price":0.45,"expiration_date":"2023-02-04","underlying":"Common Stock","underlying_shares":2000},"source":{"system":"sec-edgar","filing":"0001209191-21-019619","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1478320/000120919121019619/doc4.xml","form_type":"4"}},{"id":2796873,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":21219,"kind":"person","name":"HERSHBERG ROBERT","position":1,"cik":"0001274139","reported_name":"HERSHBERG ROBERT","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-03-11T00:00:14.000Z","date":"2021-03-08","kind":"sale","acquired":false,"shares":2000,"price":44.56,"value":89120.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 13, 2020."}],"balance_after":1504,"source":{"system":"sec-edgar","filing":"0001209191-21-019619","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1478320/000120919121019619/doc4.xml","form_type":"4"}},{"id":2796872,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":21219,"kind":"person","name":"HERSHBERG ROBERT","position":1,"cik":"0001274139","reported_name":"HERSHBERG ROBERT","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-03-11T00:00:14.000Z","date":"2021-03-08","kind":"exercise","acquired":true,"shares":2000,"price":0.45,"value":900.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 13, 2020."}],"balance_after":3504,"source":{"system":"sec-edgar","filing":"0001209191-21-019619","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1478320/000120919121019619/doc4.xml","form_type":"4"}},{"id":2849715,"issuer":{"id":15988,"kind":"organization","name":"NanoString Technologies Inc","symbol":"NSTG"},"owners":[{"id":21219,"kind":"person","name":"HERSHBERG ROBERT","position":1,"cik":"0001274139","reported_name":"HERSHBERG ROBERT","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2021-02-18T16:23:54.000Z","date":"2021-02-16","kind":"exercise","acquired":false,"shares":1188,"price":11.2,"value":13305.6,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"50% of the shares subject to the Option vest on the one year anniversary of March 2, 2015 (the \"Vesting Commencement Date\") and thereafter the remaining 50% of the total shares vest in twelve equal monthly installments on each monthly anniversary of the Vesting Commencement Date, subject to continued service as a director through each vesting date."}],"balance_after":1500,"derivative":{"exercise_price":11.2,"expiration_date":"2025-03-01","underlying":"Common Stock","underlying_shares":1188},"source":{"system":"sec-edgar","filing":"0001401708-21-000020","document":"wf-form4_161368339802845.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1401708/000140170821000020/wf-form4_161368339802845.xml","form_type":"4"}},{"id":2849714,"issuer":{"id":15988,"kind":"organization","name":"NanoString Technologies Inc","symbol":"NSTG"},"owners":[{"id":21219,"kind":"person","name":"HERSHBERG ROBERT","position":1,"cik":"0001274139","reported_name":"HERSHBERG ROBERT","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-02-18T16:23:54.000Z","date":"2021-02-16","kind":"sale","acquired":false,"shares":69,"price":83.93,"value":5791.17,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported by Dr. Hershberg were effected pursuant to a Rule 10b5-1 trading plan adopted on March 15, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"The \"Amount\" and \"Price\" reported in this Column 4 reflect the aggregate number and weighted-average price, respectively, of shares sold. These shares were sold in multiple transactions at prices ranging from $83.94 to $84.65, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein."}],"balance_after":1890,"source":{"system":"sec-edgar","filing":"0001401708-21-000020","document":"wf-form4_161368339802845.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1401708/000140170821000020/wf-form4_161368339802845.xml","form_type":"4"}},{"id":2849713,"issuer":{"id":15988,"kind":"organization","name":"NanoString Technologies Inc","symbol":"NSTG"},"owners":[{"id":21219,"kind":"person","name":"HERSHBERG ROBERT","position":1,"cik":"0001274139","reported_name":"HERSHBERG ROBERT","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-02-18T16:23:54.000Z","date":"2021-02-16","kind":"sale","acquired":false,"shares":163,"price":82.83,"value":13501.29,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported by Dr. Hershberg were effected pursuant to a Rule 10b5-1 trading plan adopted on March 15, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The \"Amount\" and \"Price\" reported in this Column 4 reflect the aggregate number and weighted-average price, respectively, of shares sold. These shares were sold in multiple transactions at prices ranging from $82.54 to $82.98, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein."}],"balance_after":1959,"source":{"system":"sec-edgar","filing":"0001401708-21-000020","document":"wf-form4_161368339802845.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1401708/000140170821000020/wf-form4_161368339802845.xml","form_type":"4"}},{"id":2849712,"issuer":{"id":15988,"kind":"organization","name":"NanoString Technologies Inc","symbol":"NSTG"},"owners":[{"id":21219,"kind":"person","name":"HERSHBERG ROBERT","position":1,"cik":"0001274139","reported_name":"HERSHBERG ROBERT","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-02-18T16:23:54.000Z","date":"2021-02-16","kind":"sale","acquired":false,"shares":156,"price":81.79,"value":12759.24,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported by Dr. Hershberg were effected pursuant to a Rule 10b5-1 trading plan adopted on March 15, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The \"Amount\" and \"Price\" reported in this Column 4 reflect the aggregate number and weighted-average price, respectively, of shares sold. These shares were sold in multiple transactions at prices ranging from $81.415 to $81.95, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein."}],"balance_after":2122,"source":{"system":"sec-edgar","filing":"0001401708-21-000020","document":"wf-form4_161368339802845.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1401708/000140170821000020/wf-form4_161368339802845.xml","form_type":"4"}},{"id":2849711,"issuer":{"id":15988,"kind":"organization","name":"NanoString Technologies Inc","symbol":"NSTG"},"owners":[{"id":21219,"kind":"person","name":"HERSHBERG ROBERT","position":1,"cik":"0001274139","reported_name":"HERSHBERG ROBERT","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-02-18T16:23:54.000Z","date":"2021-02-16","kind":"sale","acquired":false,"shares":159,"price":80.55,"value":12807.45,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported by Dr. Hershberg were effected pursuant to a Rule 10b5-1 trading plan adopted on March 15, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The \"Amount\" and \"Price\" reported in this Column 4 reflect the aggregate number and weighted-average price, respectively, of shares sold. These shares were sold in multiple transactions at prices ranging from $80.21 to $80.95, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein."}],"balance_after":2278,"source":{"system":"sec-edgar","filing":"0001401708-21-000020","document":"wf-form4_161368339802845.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1401708/000140170821000020/wf-form4_161368339802845.xml","form_type":"4"}},{"id":2849710,"issuer":{"id":15988,"kind":"organization","name":"NanoString Technologies Inc","symbol":"NSTG"},"owners":[{"id":21219,"kind":"person","name":"HERSHBERG ROBERT","position":1,"cik":"0001274139","reported_name":"HERSHBERG ROBERT","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-02-18T16:23:54.000Z","date":"2021-02-16","kind":"sale","acquired":false,"shares":323,"price":79.53,"value":25688.19,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported by Dr. Hershberg were effected pursuant to a Rule 10b5-1 trading plan adopted on March 15, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The \"Amount\" and \"Price\" reported in this Column 4 reflect the aggregate number and weighted-average price, respectively, of shares sold. These shares were sold in multiple transactions at prices ranging from $78.975 to $79.81, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein."}],"balance_after":2437,"source":{"system":"sec-edgar","filing":"0001401708-21-000020","document":"wf-form4_161368339802845.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1401708/000140170821000020/wf-form4_161368339802845.xml","form_type":"4"}},{"id":2849709,"issuer":{"id":15988,"kind":"organization","name":"NanoString Technologies Inc","symbol":"NSTG"},"owners":[{"id":21219,"kind":"person","name":"HERSHBERG ROBERT","position":1,"cik":"0001274139","reported_name":"HERSHBERG ROBERT","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-02-18T16:23:54.000Z","date":"2021-02-16","kind":"sale","acquired":false,"shares":318,"price":78.4,"value":24931.2,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported by Dr. Hershberg were effected pursuant to a Rule 10b5-1 trading plan adopted on March 15, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The \"Amount\" and \"Price\" reported in this Column 4 reflect the aggregate number and weighted-average price, respectively, of shares sold. These shares were sold in multiple transactions at prices ranging from $77.95 to $78.81, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein."}],"balance_after":2760,"source":{"system":"sec-edgar","filing":"0001401708-21-000020","document":"wf-form4_161368339802845.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1401708/000140170821000020/wf-form4_161368339802845.xml","form_type":"4"}},{"id":2849708,"issuer":{"id":15988,"kind":"organization","name":"NanoString Technologies Inc","symbol":"NSTG"},"owners":[{"id":21219,"kind":"person","name":"HERSHBERG ROBERT","position":1,"cik":"0001274139","reported_name":"HERSHBERG ROBERT","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-02-18T16:23:54.000Z","date":"2021-02-16","kind":"exercise","acquired":true,"shares":1188,"price":11.2,"value":13305.6,"ownership":{"direct":true},"balance_after":3078,"source":{"system":"sec-edgar","filing":"0001401708-21-000020","document":"wf-form4_161368339802845.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1401708/000140170821000020/wf-form4_161368339802845.xml","form_type":"4"}}],"next_cursor":"2021-02-18T16:23:54.000000Z,2849708"}